ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα2
Andreas M. Fritzen(University of Copenhagen), Bente Kiens(University of Copenhagen), Anne‐Marie Lundsgaard(University of Copenhagen), Jørgen F. P. Wojtaszewski(University of Copenhagen), Christian S. Carl, Joan Domingo‐Espín(Lund University), Ida Marchen Egerod Israelsen(University of Copenhagen), Jens O. Lagerstedt(Lund University), Trine S. Nicolaisen(University of Copenhagen), Rasmus Kjøbsted(University of Copenhagen), Jacob Jeppesen(Novo Nordisk (Denmark)), Maximilian Kleinert(University of Potsdam)
Cited by 52
Related Papers
Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance
|Nature Medicine|2000|755
Knockout of the α2 but Not α1 5′-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle
|Journal of Biological Chemistry|2004|548
The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity
|Journal of Clinical Investigation|2003|488